Kainova Therapeutics
PrivateLast Round
Series B
Feb 10, 2026
Total Funding Raised
$72.31M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Kainova Therapeutics is a clinical-stage biopharmaceutical company that develops G protein-coupled receptor (GPCR)-modulating therapies for immuno-oncology and inflammation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kainova Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Kainova Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 10, 2026 | ||||
| Series A | May 10, 2022 | ||||
| Grant | Jan 27, 2022 | ||||
| Debt | Jan 13, 2020 | ||||
| VC Round | May 28, 2019 | ||||
VC Round | Jul 17, 2012 |
Key People
Founding team and executive leadership
Kainova Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investissement Québec | Series B |
| Idinvest Partners | VC Round |
| IP Group | VC Round |
| CTI Life Sciences Fund | Series B, Series A |
| Andera Partners | VC Round |
| Agence Nationale de la Recherche | Grant |
| 3B FUTURE Health Fund | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors grew 38% MoM, reaching 1.2K.
- May 16, 2026
Grew 21% QoQ, from 38 to 46 employees.
Kainova Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kainova Therapeutics's valuation, stock price, and market status.